Get started
Award

70115044

Funded outputs count: 11
Funder award ID: 70115044
OpenAlex ID: G202481242
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist
2026 · Binje Vick, Vindi Jurinovic, et al. · HemaSphere
PDF
Rapid and reproducible karyotyping with long-read sequencing in patients with AML
2026 · Michael Heuser, Anna Dolnik, et al. · Blood Advances
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia
2026 · Rabea Mecklenbrauck, Angela Villaverde Ramiro, et al. · Leukemia · 2
PDF
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
2025 · Jacqueline Cloos, Peter J. M. Valk, et al. · Blood · 83
PDF
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.
2025 · Mecklenbrauck, Rabea, Villaverde Ramiro, Angela, et al. · Apollo (University of Cambridge)
PDF
Prognostic implications of right ventricular to pulmonary artery uncoupling in cardiac amyloidosis
2025 · Aiste Monika Jakstaite, Anja Hänselmann, et al. · Frontiers in Cardiovascular Medicine · 2
PDF
Clec12a is required for the pathogenesis of NUP98::NSD1 AML
2025 · Sagarajit Mohanty, Fiorella Charles Cano, et al. · Blood Advances · 1
PDF
Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia
2025 · Rabea Mecklenbrauck, Nora Borchert, et al. · Leukemia · 8
PDF
Cell‐free DNA for detection and monitoring of extramedullary AML relapse
2025 · Henri C. Hupe, Clara P. Wienecke, et al. · HemaSphere · 8
PDF
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents
2025 · Rabia Shahswar, Razif Gabdoulline, et al. · Leukemia · 28
PDF
Relapse Prevention in Acute Myeloid Leukemia: The Role of Immunotherapy with Histamine Dihydrochloride and Low-Dose Interleukin-2
2024 · Pau Montesinos, Francesco Buccisano, et al. · Cancers · 3
PDF
Year
Topic